Lipigon Pharmaceuticals AB (publ) (STO:LPGO)
Sweden · Delayed Price · Currency is SEK 0.0148
-0.0002 (-1.33%)
Jan 21, 2026, 3:52 PM CET
STO:LPGO Market Cap
STO:LPGO has a market cap or net worth of 9.09 million as of January 21, 2026. Its market cap has decreased by -46.90% in one year.
Market Cap
9.09M
Enterprise Value
-7.51M
Revenue
1.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since March 1, 2021, STO:LPGO's market cap has decreased from 97.91M to 9.09M, a decrease of -90.72%. That is a compound annual growth rate of -38.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 9.09M | 74.42% |
| Dec 30, 2025 | 5.21M | -69.56% |
| Dec 30, 2024 | 17.12M | -68.59% |
| Dec 29, 2023 | 54.49M | 240.70% |
| Dec 30, 2022 | 15.99M | -74.72% |
| Dec 30, 2021 | 63.26M | -35.39% |
| Mar 1, 2021 | 97.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 114.29B |
| Getinge AB | 60.57B |
| BioArctic AB | 48.85B |
| Sectra AB | 44.35B |
| Camurus AB | 41.24B |
| Medicover AB | 31.93B |
| Asker Healthcare Group AB | 30.15B |
| Elekta AB | 24.17B |